Tampa, FL, United States of America

Clayton A Smith

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Duke University. Active years: 2003-2010.


% Patents Active = 50.0


 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 51(Granted Patents)


Location History:

  • Durham, NC (US) (2003)
  • Tampa, FL (US) (2003 - 2010)

Company Filing History:


Years Active: 2003-2010

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Clayton A. Smith: Innovator in Stem Cell Research

Introduction

Clayton A. Smith is a prominent inventor based in Tampa, Florida, known for his significant contributions to the field of stem cell research. With a total of 4 patents to his name, Smith has made strides in developing methods that enhance the isolation and application of stem cells.

Latest Patents

Among his latest innovations is a patent for a method of isolating stem cells. This invention focuses on the techniques and reagents necessary for effectively isolating stem cells, which are crucial for various medical applications. The method not only improves the efficiency of stem cell isolation but also ensures the quality of the stem cell populations that can be obtained.

Career Highlights

Clayton A. Smith is affiliated with Duke University, where he continues to advance his research in stem cell technology. His work has garnered attention in the scientific community, contributing to the understanding and potential therapeutic uses of stem cells.

Collaborations

Smith collaborates with notable colleagues, including Robert Storms and Susan M. Ludeman, who share his passion for innovation in the field of stem cell research.

Conclusion

Clayton A. Smith's contributions to stem cell research through his patents and collaborations highlight his role as a key innovator in this vital area of science. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…